California's Biotech Industry Plans $5.3 Billion in Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--California has one of the largest biotechnology clusters in the world. According to a report from the…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech

Industrial Info

Thu May 06 2021

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech | Capital Projects

Industrial Info

Thu Apr 29 2021

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons,…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech | Project Spending

Industrial Info

Wed Apr 21 2021

COVID-19 Pandemic Increases Demand for Vaccine Delivery Devices

Researched by Industrial Info Resources (Sugar Land, Texas)--As companies continue to develop vaccines to combat the pandemic, there is a growing need for needles,…

Industrial Info | covid | IIR | Pharmaceutical & Biotech | pharmaceutical | manufacturing

jwebb

Industrial Info

Thu Apr 08 2021

Russia Taps Italy to Manufacture Sputnik V COVID-19 Vaccine

Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Russia's COVID-19 vaccine, Sputnik V, will be produced for the first time in…

Industrial Info | covid | manufacturing | IIR | pharmaceutical | Pharmaceutical & Biotech

Industrial Info

Mon Mar 15 2021

California's Biotech Industry Plans $5.3 Billion in Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--California has one of the largest biotechnology clusters in the world. According to a report from the California Life Sciences Association (CLSA), this sector employed roughly 324,000 people and generated $6.4 billion in direct state and local taxes in 2020, with 1,350 new medicines in clinical trials, including COVID-19 »

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada have relied heavily on countries such as China, India and Italy to supply these ingredients in a timely and economic manner. But the pandemic fueled a need to produce active pharmaceutical ingredients (APIs) domestically to »

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons, with a year-over-year growth of 20.2%. In 2020, capacity was 2.734 million tons, a slight downturn attributed to the COVID-19 pandemic. The annual output of China's active pharmaceutical ingredients (APIs) stabilized at about »

COVID-19 Pandemic Increases Demand for Vaccine Delivery Devices

Researched by Industrial Info Resources (Sugar Land, Texas)--As companies continue to develop vaccines to combat the pandemic, there is a growing need for needles, syringes and other vaccine delivery devices. Companies like Apiject and Becton and Dickenson (BD) are investing millions to produce the ancillary equipment needed for the vaccines. Apiject is investing nearly a billion dollars for a »

Russia Taps Italy to Manufacture Sputnik V COVID-19 Vaccine

Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Russia's COVID-19 vaccine, Sputnik V, will be produced for the first time in Europe at a manufacturing facility in Italy. The deal has been confirmed by Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF) and the Italian-Russian Chamber of Commerce, just over a week after the European »